SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT CO., LTD.

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

600613

CNE000000453

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
5.35 ^CNY	-0.37%		-2.55%	-29.70%

04-29	Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-29	Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. completed the acquisition of 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. from Guizhou Shenqi Holdings Co., Ltd.

April 17, 2024

Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) from Guizhou Shenqi Holdings (Group) Co., Ltd. for CNY 190 million on March 21, 2024.
Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. completed the acquisition of 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) from Guizhou Shenqi Holdings (Group) Co., Ltd. on April 18, 2024.

Latest news about Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. completed the acquisition of 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. from Guizhou Shenqi Holdings Co., Ltd.	04-17	CI
Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. from Guizhou Shenqi Holdings Co., Ltd. for CNY 190 million.	03-25	CI
Whirlpool China : China blue-chips end higher on rising factory activity	02/11/20	RE

Chart Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Duration

Period

Chart Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

More charts

Company Profile

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Companyâs products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.

Sector

Pharmaceuticals

Calendar

01/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT CO., LTD.	-29.70%	376M
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+43.12%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+15.87%	242B
ROCHE HOLDING AG	+2.00%	224B
NOVARTIS AG	+13.04%	218B
AMGEN INC.	+8.48%	168B